Heterogeneity of Histological Transformation Events in Waldenström's Macroglobulinemia (WM) and Related Disorders
- 1 February 2011
- journal article
- case report
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 11 (1), 176-179
- https://doi.org/10.3816/clml.2011.n.042
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Clinical Outcomes and Prognostic Factors in Patients With Richter's Syndrome Treated With Chemotherapy or Chemoimmunotherapy With or Without Stem-Cell TransplantationJournal of Clinical Oncology, 2006
- Fludarabine plus cyclophosphamide in Waldenström's macroglobulinemia: results in 49 patientsLeukemia, 2005
- Richter's transformation of chronic lymphocytic leukemia: The possible role of fludarabine and the Epstein–Barr virus in its pathogenesisLeukemia Research, 2005
- Richter syndromeCancer, 2005
- Diffuse Large B-Cell Lymphoma Occurring in Patients With Lymphoplasmacytic Lymphoma/Waldenström MacroglobulinemiaAmerican Journal of Clinical Pathology, 2003
- Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 casesBritish Journal of Haematology, 2001
- Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory diseaseBlood, 2001
- Waldenström MacroglobulinemiaAmerican Journal of Clinical Pathology, 2001
- Activity of fludarabine in previously treated Waldenström's macroglobulinemia: a report of 71 cases. Groupe Coopératif Macroglobulinémie.Journal of Clinical Oncology, 1998
- Prognostic factors in Waldenström's macroglobulinemia: a report of 167 cases.Journal of Clinical Oncology, 1993